BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16275181)

  • 1. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
    Beckman JA; Preis O; Ridker PM; Gerhard-Herman M
    Am J Cardiol; 2005 Nov; 96(10):1374-8. PubMed ID: 16275181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.
    Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Savvidis S; Messow CM; Munzel T; Blankenberg S;
    Circulation; 2008 Aug; 118(9):961-7. PubMed ID: 18697822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2005 Aug; 112(7):976-83. PubMed ID: 16087797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
    Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
    J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease.
    Brevetti G; Schiano V; Laurenzano E; Giugliano G; Petretta M; Scopacasa F; Chiariello M
    Eur Heart J; 2008 Jan; 29(2):224-30. PubMed ID: 18156137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease.
    Feringa HH; Karagiannis SE; Schouten O; Vidakovic R; van Waning VH; Boersma E; Welten G; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):206-13. PubMed ID: 17481930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of biomarkers and genetics in peripheral arterial disease.
    McDermott MM; Lloyd-Jones DM
    J Am Coll Cardiol; 2009 Sep; 54(14):1228-37. PubMed ID: 19778662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.
    Diehm C; Allenberg JR; Pittrow D; Mahn M; Tepohl G; Haberl RL; Darius H; Burghaus I; Trampisch HJ;
    Circulation; 2009 Nov; 120(21):2053-61. PubMed ID: 19901192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs.
    de Haro Miralles J; Martínez-Aguilar E; Florez A; Varela C; Bleda S; Acin F
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):107-12. PubMed ID: 19376804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral arterial disease in patients with stages IV and V chronic renal failure.
    Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A
    Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study.
    Brevetti G; Giugliano G; Oliva G; Lanero S; De Maio JI; Chiariello M
    QJM; 2008 Jul; 101(7):575-82. PubMed ID: 18463142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.